PhUSE SDE San Francisco 2011
Using Biomarkers to Enable Drug Development for Asthma
Joe Arron, MD PhD, Genentech
Assessment of Tumor Gentoypes in Metastatic Colorectal Cancer (mCRC):
Mutations beyond KRAS Codons 12 and 13 as Predictive Biomarkers of
Responses to Panitumumab (pmab) in a Randomized, Phase 3 Monotherapy
StudyJing Huang, PhD, Amgen
Diagnostics 101 for SAS ProfessionalsCarey Smoak, Roche
Levaraging Biomarkers in Early Clinical Drug Development for Metabolic Disease TherapiesMalle Jurima-Romet, PhD, Celerion
Right Drugs for the Right Patients
Jane Fridlyand, PhD, Genentech
CDISC Membership Benefits and Education OfferingsDiana El-Harakeh, CDISC
CDISC Therapeutic Area Data Standards: Expanding Collaboration with Clinicians and Federal Health AgenciesBron Kisler, CDISC
Alzheimer's Disease Standards: A Collaboration between CDISC and the Critical Path InstituteJon Neville, C-Path
Annotation Analysis For Testing Drug Safety SignalsTrish Whetzel, PhD, Stanford University
CDISC SHARE - A New Approach to Finding, Understanding and Using Clinical DataRhonda Facile, CDISC-NCI